Measuring reversal of HIV-1 latency ex vivo using cells from infected individuals

Proc Natl Acad Sci U S A. 2014 May 13;111(19):6860-1. doi: 10.1073/pnas.1405194111. Epub 2014 May 5.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Anti-Retroviral Agents / therapeutic use*
  • CD4-Positive T-Lymphocytes / virology*
  • Female
  • HIV Infections / drug therapy*
  • HIV-1 / growth & development*
  • Humans
  • Hydroxamic Acids / therapeutic use*
  • Male
  • Virus Latency / drug effects*
  • Vorinostat

Substances

  • Anti-Retroviral Agents
  • Hydroxamic Acids
  • Vorinostat